ACM
WST icon

AlphaCrest Capital Management’s West Pharmaceutical WST Stock Holding History

AlphaCrest Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,199
Closed -$2.26M – 1157
2022
Q3 		$2.26M Buy
9,199
+4,166
+83% +$1.27M 0.14% 192
2022
Q2 		$1.52M Buy
5,033
+3,020
+150% +$983K 0.07% 466
2022
Q1 		$827K Sell
2,013
-117
-5% -$45.8K 0.05% 642
2021
Q4 		$999K Sell
2,130
-772
-27% -$332K 0.04% 789
2021
Q3 		$1.23M Sell
2,902
-2,422
-45% -$1.02M 0.06% 517
2021
Q2 		$1.91M Buy
5,324
+4,613
+649% +$1.52M 0.08% 380
2021
Q1 		$200K Sell
711
-1,767
-71% -$506K 0.01% 1147
2020
Q4 		$702K Buy
2,478
+1,302
+111% +$365K 0.06% 471
2020
Q3 		$323K Buy
+1,176
New +$311K 0.04% 821
2020
Q1 		– Sell
-2,950
Closed -$443K – 1301
2019
Q4 		$443K Buy
2,950
+589
+25% +$85.8K 0.04% 866
2019
Q3 		$335K Sell
2,361
-10
-0.4% -$1.38K 0.02% 1075
2019
Q2 		$297K Sell
2,371
-597
-20% -$70.5K 0.03% 861
2019
Q1 		$327K Buy
+2,968
New +$309K 0.05% 621

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCrest Capital Management's WST Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 9,199 shares — an estimated $2.26M sold.

AlphaCrest Capital Management first reported a position in WST in Q1 2019 and held it in 13 quarters. The position peaked at $2.26M in Q3 2022. 638 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 9,199 West Pharmaceutical shares in Q4 2022, an estimated $2.26M.
  • AlphaCrest Capital Management first reported a position in West Pharmaceutical in Q1 2019 and held it in 13 quarters.
  • AlphaCrest Capital Management's West Pharmaceutical position peaked at $2.26M in Q3 2022.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.